Literature DB >> 10825573

Nuclear magnetic relaxation dispersion profiles of substantia nigra pars compacta in Parkinson's disease patients are consistent with protein aggregation.

L Lopiano1, M Fasano, S Giraudo, G Digilio, S H Koenig, E Torre, B Bergamasco, S Aime.   

Abstract

Nuclear Magnetic Relaxation field-cycling relaxometry is a technique, able to report on water mobility in tissues. By means of this technique, post-mortem specimens from both controls and idiopathic Parkinson's disease patients have been investigated. Results show different relaxometric behavior between the groups, which is consistent with protein aggregation in Parkinson's disease specimens.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10825573     DOI: 10.1016/s0197-0186(00)00036-x

Source DB:  PubMed          Journal:  Neurochem Int        ISSN: 0197-0186            Impact factor:   3.921


  5 in total

Review 1.  Is neuromelanin changed in Parkinson's disease? Investigations by magnetic spectroscopies.

Authors:  M Fasano; B Bergamasco; L Lopiano
Journal:  J Neural Transm (Vienna)       Date:  2006-05-12       Impact factor: 3.575

2.  High-field (9.4 T) MRI of brain dysmyelination by quantitative mapping of magnetic susceptibility.

Authors:  Chunlei Liu; Wei Li; G Allan Johnson; Bing Wu
Journal:  Neuroimage       Date:  2011-02-12       Impact factor: 6.556

3.  Decreased catalase expression and increased susceptibility to oxidative stress in primary cultured corneal fibroblasts from patients with granular corneal dystrophy type II.

Authors:  Seung-il Choi; Tae-im Kim; Kyu Seo Kim; Bong-Yoon Kim; So-yeon Ahn; Hyun-ju Cho; Hyung Keun Lee; Hyun-Soo Cho; Eung Kweon Kim
Journal:  Am J Pathol       Date:  2009-06-04       Impact factor: 4.307

Review 4.  Proteomic approach to studying Parkinson's disease.

Authors:  Jing Zhang; David R Goodlett
Journal:  Mol Neurobiol       Date:  2004-06       Impact factor: 5.590

Review 5.  Role for the ubiquitin-proteasome system in Parkinson's disease and other neurodegenerative brain amyloidoses.

Authors:  Darren J Moore; Valina L Dawson; Ted M Dawson
Journal:  Neuromolecular Med       Date:  2003       Impact factor: 4.103

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.